Clinical trials of a stromelysin inhibitor: Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 201-207

  Leff, Richard L ^a  

^a BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4,4 (CHLOROPHENYL)PHENYL] 4 OXO (PHENYLTHIOMETHYL)BUTANOIC ACID; MATRIX METALLOPROTEINASE; STROMELYSIN; STROMELYSIN INHIBITOR; UNCLASSIFIED DRUG;

CARTILAGE DEGENERATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; ENZYME INHIBITION; HUMAN; NONHUMAN; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT;

EID: 0032816497     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07685.x     Document Type: Conference Paper

References (12)

1. 1. Dequeker, J. & L. Van De Putte. 1994. Disorders of bone, cartilage, and connective tissue. In Rheumatology. J.H. Klippel & P.A. Dieppe, Eds. Mosby-Year Book Europe Ltd. London.
2. 2. Woessner, J.F., Jr. & Z. Guanja-Smith. 1991. Role of metalloproteinases in human osteoaritis. J. Rheumatol. Suppl. 27: 99-101.
3. 3. Birkedal-Hansen, H., W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo & J.A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4(2): 197-250.
4. 4. Lohmander, L.S., L.A. Hoerrner & M.W. Lark. 1993. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arth. Rheum. 36(2): 181-189.
5. 5. Nagase, H. 1997. Activation of matrix metalloproteinases. Biol. Chem. 378: 151-160.
6. 6. Billinghurst R.C., K. O'Brien, A.R. Poole & C.W. McIlwraith. Inhibition of articular cartilage degradation in culture by a novel non-peptidic matrix metalloproteinase inhibitor. This volume.
7. 7. Chau, T., G. Jolly, J.M. Plym et al. 1998. Inhibition of articular cartilage degradation in dog and guinea pig models of osteoarthritis by the stromelysin inhibitor, BAY 12-9566. Arth. Rheum. 41(9S): S300.
8. 8. 1996. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Special Report. Osteoarth. Cartil. 4: 217-243.
9. 9. Buckland-Wright, J.C. 1997. Current status of imaging procedures in the diagnosis, prognosis and monitoring of osteoarthritis. Baillieres Clin. Rheumatol. 11(4): 727-748.
10. 10. Myers, S.I., B.L. O'Connor & K.D. Brandt. 1996. Accelerated clearance of albumin from the osteoarthritis knee: implications for interpretation of concentrations of "cartilage markers" in synovial fluid. J. Rheumatol. 23(10): 1744-1747.
11. 11. Omeract III. 1997. Outcome measures in arthritis clinical trials. Cairns, Australia, April 16-19, 1996. Proceedings. J. Rheumatol. 24(4): 763-802.
12. 12. Loeuille, D., P. Olivier, D. Mainard, P. Gillet, P. Netter & A. Blum. 1998. Review: magnetic resonance imaging of normal and osteoarthritic cartilage. Arth. Rheum. 41(6): 963-975.